Kennon-Green & Company’s AbbVie ABBV Stock Holding History

Kennon-Green & Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340K	Sell	1,351 -10	-0.7%	-$2.15K	0.27%	38
2026 Q1	$296K	Sell	1,361 -25	-2%	-$5.55K	0.24%	37
2025 Q4	$317K	Sell	1,386 -71	-5%	-$16.2K	0.25%	36
2025 Q3	$337K	Sell	1,457 -3	-0.2%	-$611	0.26%	37
2025 Q2	$277K	Buy	1,460 +15	+1%	+$2.79K	0.22%	38
2025 Q1	$303K	Sell	1,445 -25	-2%	-$4.86K	0.25%	39
2024 Q4	$261K	Sell	1,470 -30	-2%	-$5.52K	0.23%	41
2024 Q3	$296K	Sell	1,500 -4	-0.3%	-$747	0.25%	40
2024 Q2	$258K	Sell	1,504 -77	-5%	-$12.8K	0.24%	40
2024 Q1	$288K	Sell	1,581 -25	-2%	-$4.31K	0.27%	40
2023 Q4	$249K	Sell	1,606 -105	-6%	-$15.3K	0.25%	40
2023 Q3	$255K	Sell	1,711 -46	-3%	-$6.75K	0.25%	43
2023 Q2	$237K	Sell	1,757 -25	-1%	-$3.67K	0.22%	43
2023 Q1	$284K	Sell	1,782 -75	-4%	-$11.5K	0.27%	40
2022 Q4	$300K	Buy	+1,857	New	+$285K	0.3%	37

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kennon-Green & Company's ABBV Position: Q2 2026 in Review

Kennon-Green & Company reduced its AbbVie (ABBV) stake by 0.73% in Q2 2026, selling an estimated $2.15K and leaving 1,351 shares worth $340K. The position accounts for 0.27% of the portfolio, ranked #38.

Kennon-Green & Company first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Kennon-Green & Company held 1,351 shares of AbbVie worth $340K as of Q2 2026.
Kennon-Green & Company sold 10 AbbVie shares in Q2 2026, an estimated $2.15K.
AbbVie made up 0.27% of Kennon-Green & Company's portfolio in Q2 2026, its #38 holding.
Kennon-Green & Company first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kennon-Green & Company's 13F filing for Q2 2026, filed 6 Aug 2026.